Autoimmune Market Research Reports & Industry Analysis
Classification of autoimmune disorders is still somewhat controversial, but the following criteria is generally accepted: Direct evidence from transfer of pathogenic antibody or pathogenic T cells, indirect evidence based on reproduction of the autoimmune disease in experimental animals, and circumstantial evidence from clinical clues
Arthritis is among the most common autoimmune disorders. Arthritis is joint inflammation The major complaint by individuals who have arthritis is joint pain. Pain is often a constant and may be localized to the joint affected. There are over one hundred forms different forms The most common form, osteoarthritis (degenerative joint disease) is a result of trauma to the joint, infection of the joint, or age. Other arthritis forms are rheumatoid arthritis, psoriatic arthritis, and related autoimmune diseases. Septic arthritis is caused by joint infection. Treatment options vary depending on the type of arthritis and include physical therapy, exercise and weight control, bracing, medications. Surgery may be required in some changes.
Autoimmune Industry Research & Market Reports
-
Autoimmune Drugs Industry Forecasts - China Focus
... China have transformed China’s society and economy. China is one of the world’s major producers for industrial and consumer products. Far outpacing other economies in the world, China is the world’s fastest growing market for ... Read More
-
US Apheresis Service Market Research Report Information by Service Type (Donor/Automated Apheresis, Therapeutic Apheresis, and Stem Cell Collection and Processing), by Application (Neurological Disorders, Autoimmune Disorders, Hematologic Disorders, Oncology, Metabolic Toxicology Disorders, Infectious Diseases, Cardiovascular Disorders, and Others), by End User (Hospitals, Blood Banks, Specialty Clinics, Research Laboratories, and Biotechnology Pharmaceutical Companies) Industry Forecast to 2035
... specific component (such as plasma, platelets, or white blood cells), and returning the remaining blood to the body. It is commonly employed for therapeutic objectives, including as removing excess components in particular disorders (for example, ... Read More
-
Eosinophilic Esophagitis Market, by Drug Class (Corticosteroids: Budesonide {Jorveza and Off-label budesonide} and Fluticasone; Proton Pump Inhibitor (PPI): Omeprazole, Esomeprazole, and Others; and Late Stage Pipeline Drugs: Dupixent, APT-1011, Lirentelimab (AK002), Cendakimab, Etrasimod, TAK-721, and Omilancor (BT-11)), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2025 - 2032
... as a liquid. Oral steroids may be prescribed to treat people who have serious swallowing problems or weight loss. Proton pump inhibitors help with reflux symptoms and decrease inflammation. Market Dynamics Growing awareness regarding eosinophilic ... Read More
-
Antiphospholipid Syndrome Treatment Global Market Report 2025
... market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond. Reasons to Purchase Gain a truly global perspective ... Read More
-
Injectable Drug Delivery Devices Global Market Report 2025
... delivery devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond. Reasons to Purchase Gain a truly ... Read More
-
Small Molecule Active Pharmaceutical Ingredient Global Market Report 2025
... molecule active pharmaceutical ingredient market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond. Reasons to Purchase Gain ... Read More
-
Systemic Lupus Erythematosus (SLE) Drugs Market by Drug Class (Antimalarials Drugs, Non-Steroidal Anti-Inflammatory Drugs (NSAIDS), Cytotoxic and Immunosuppressive Drugs, Biologics, and Others), Mode of Delivery (Intravenous, Subcutaneous, Oral), and Region 2025-2033
... 5.54% during 2025-2033. The increasing number of patients suffering from SLE, rising public awareness campaigns, and the easy availability of generic drugs represent some of the key factors driving the market. Systemic lupus erythematosus (SLE) ... Read More
-
Systemic Lupus Erythematosus Treatment Global Market Report 2025
... erythematosus treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond. Reasons to Purchase Gain a truly ... Read More
-
Companion Diagnostics Market Size, Share, By Offerings (Products and Services), Technology (Polymerase Chain Reaction (PCR), Next-generation Sequencing (NGS), Immunohistochemistry (IHC), Fluorescence In Situ Hybridization (FISH), and, Others), Therapeutic Area (Oncology, Immunology, Neurology, Autoimmune, Cardiovascular, Infectious Disease, and Others), End-User (Pharmaceutical & Biotechnological Companies, Contract Research Laboratories, Diagnostics Laboratories, and Others), and Region - Trends, Analysis, and Forecast till 2035
... Disease, and Others), End-User (Pharmaceutical & Biotechnological Companies, Contract Research Laboratories, Diagnostics Laboratories, and Others), and Region - Trends, Analysis, and Forecast till 2035 Companion diagnostics market is projected to grow from US$ 3.6 Billion ... Read More
-
PEGylated Drugs Market Research Report Information by Molecule (Macromolecular Drugs, Small Molecular Drugs and Lipid Nanoparticles (LNP) and Liposomes), by Application (Oncology, Neurology, Autoimmune Diseases, Haematology and Others), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies) and by Region (Americas, Europe, Asia-Pacific and the Middle East & Africa) Industry Forecast till 2035
... fragments, enzymes, and oligonucleotides, to covalent and non-covalent glycol polymer chains. It is a secure technique that is employed to enhance the therapeutic efficacy of medications in a clinical setting. Numerous pegylated pharmaceuticals have been ... Read More
-
Global Difficult-to-Express Proteins Market - 2023-2030
... to exhibit a CAGR of 11.0% during the forecast period (2024-2031). Prokaryotic expression system research and development have increased due to the rising demand for recombinant proteins and this trend is anticipated to fuel market ... Read More
-
Global Eosinophilic Esophagitis (EoE) Treatment Market - 2024 - 2031
... large numbers of white blood cells called eosinophils are present in the esophagus. It causes an inflammation of the esophagus caused by an overabundance of certain white blood cells. Food allergies are thought to be ... Read More
-
Global Oral Transmucosal Drugs Market- 2023-2030
... to exhibit a CAGR of 6.4% during the forecast period (2023-2030). Oraltransmucosal drug administration was an alternative route in end-of-life care and palliative care during the COVID-19 pandemic. Oral transmucosal drug delivery is the systemic ... Read More
-
Stem Cell Therapy Market, By Cell Source (Adult Stem Cells, Induced Pluripotent Stem Cells, Embryonic Stem Cells, Others), By Application (Musculoskeletal Disorders, Wounds and Injuries, Cancer, Autoimmune Disorders, Others), By End User (Hospitals, Cell Banks , Academic and Research Institutes), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)
... promising and emerging field in regenerative medicine that involves the use of stem cells and their derivatives to repair or regenerate damaged tissues and cells. Stem cells are found in all human beings from a ... Read More
-
2025 Blood & AutoImmune Diseases Global Market Size & Growth Report with Updated Analysis & Forecasts
... subregions, and 195 countries. Figures are from 2013 through 2024, with forecasts for 2025 and the next 5 years. The historical data utilizes in-depth survey results from companies selling diseases of the blood and blood-forming ... Read More
-
Biosimilars Market Research Report By Type (Monoclonal Antibodies, Insulin, Erythropoietin, Growth Hormones), By Application (Oncology, Diabetes, Autoimmune Diseases, Chronic Inflammatory Diseases), By End Use (Hospitals, Clinics, Homecare, Research Institutions), By Manufacturing Process (Recombinant DNA Technology, Hybridoma Technology, Transgenic Technology) and By Regional (North America, Europe, South America, Asia Pacific, Middle East and Africa) Industry Forecast to 2032
... of approximately 15.49%. Key factors that are driving the biosimilars market include the increasing prevalence of chronic diseases and the increasing demand for affordable biologic treatments. Biosimilars provide a cost-effective alternative that can enhance patient ... Read More
-
In Vitro Diagnostics Ivd Market, By Product (Reagents & Kits, Instruments), By Test Type (Clinical Chemistry, Immunoassay, Hematology, Molecular Diagnostics, Microbiology, Coagulation, Others), By Application (Infectious Diseases, Diabetes, Oncology, Cardiology, Nephrology, Autoimmune Disorders, Others), By End User (Hospitals & Clinics, Diagnostic Laboratories, Academic & Research Institutes, Others), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)
... testing of biological samples such as blood, urine, tissues, and others for detection of diseases. IVD technologies allow early detection of diseases which helps in timely clinical intervention and improved patient outcomes. The market growth ... Read More
-
Europe Specialty Generics Market Report by Route of Administration (Injectables, Oral, and Others), Indication (Oncology, Autoimmune Diseases, Infectious Diseases, and Others), Distributional Channel (Retail Pharmacies, Specialty Pharmacies, Hospital Pharmacies), and Region 2025-2033
... The increasing prevalence of chronic diseases, rising demand for affordable medicines, and implementation of favorable regulatory guidelines are some of the key factors driving the market. Specialty generics refer to complex, difficult-to-produce medications that are ... Read More
-
Global Immunotherapy Drugs Market (2025 Edition): Analysis By Indication (Cancer, Autoimmune & Inflammatory Diseases, Other Indications), By Drug Type, By Region, By Country: Market Insights and Forecast (2020-2030)
... & Inflammatory Diseases, Other Indications), By Drug Type (Monoclonal Antibodies, Immunomodulators, Vaccines) for the historical period of 2020-2023, the estimates of 2024 and the forecast period of 2025-2030. The report analyses the Immunotherapy Drugs Market ... Read More
-
Innovation Insights: Cell Therapy for Autoimmune diseases
... inflammation in patients with autoimmune disorders. These cells are often derived from the patient's own body or from a donor and are administered through injections or infusions. The goal of cell therapy is to restore ... Read More
-
Global Janus Kinase (JAK) Inhibitors Market - 2024-2032
... of 8.4% during the forecast period 2024-2032. Pipeline Drugs Janus kinase is a group of proteins that are involved in the cytokine signaling pathway. These are known to play a crucial role in several autoimmune, ... Read More
-
Biosimilar Market Report by Molecule (Infliximab, Insulin Glargine, Epoetin Alfa, Etanercept, Filgrastim, Somatropin, Rituximab, Follitropin Alfa, Adalimumab, Pegfilgrastim, Trastuzumab, Bevacizumab, and Others), Indication (Auto-Immune Diseases, Blood Disorders, Diabetes, Oncology, Growth Deficiency, Female Infertility, and Others), Manufacturing Type (In-house Manufacturing, Contract Manufacturing), and Region 2025-2033
... Manufacturing Type (In-house Manufacturing, Contract Manufacturing), and Region 2025-2033 The global biosimilar market size reached USD 26.5 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 185.1 Billion by 2033, exhibiting ... Read More
-
Specialty Generics Market Report by Route of Administration (Injectables, Oral, and Others), Indication (Oncology, Autoimmune Diseases, Infectious Diseases, and Others), Distribution channel (Retail Pharmacies, Specialty Pharmacies, Hospital Pharmacies), and Region 2025-2033
... market size reached USD 81.8 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 178.6 Billion by 2033, exhibiting a growth rate (CAGR) of 9.1% during 2025-2033. There are various factors ... Read More
-
2025 Global Forecast for Autoimmune Disease Treatment Market (2026-2031 Outlook)-High Tech Outlook Report
... product or service category is within the NAICS Medical Laboratories industry. The product or service category is within the NAICS Medical Laboratories industry. The global market is expected to increase from USD xx billion in ... Read More
-
2025 Global: Diagnosis Of Autoimmune Diseases Market - Innovative Markets Forecast (2031) report
... accurate industry forecasts based on our proprietary economic models. Our forecasts project the product market size nationally and by regions for 2020 to 2031 using regression analysis in our modeling. and Perry/Hope is the only ... Read More
Research Assistance
